Chiropractors in Brielle, NJ Accepting Medicare

8 Chiropractors found. Showing 1 - 8

John J Tumas Dc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 425 Higgins Ave, Brielle, NJ 08730 Phone: 732-528-2188    Fax: 732-528-4408

Dr. Kurt D Hostnik, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 543 Woodland Ave, Brielle, NJ 08730 Phone: 732-298-2607

Dr. Michelle Lehotay, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 600 Union Ave, Brielle, NJ 08730 Phone: 732-528-6644

Drs Tumas Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 427 Euclid Ave, Brielle, NJ 08730 Phone: 732-528-2188

Tumas Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 712 Riverview Drive, Brielle, NJ 08730 Phone: 732-528-2188    Fax: 732-528-4408

Dr. Sharon O'brien, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 600 Union Ave, Suite 2, Brielle, NJ 08730 Phone: 732-528-1100

Dr. John Joseph Tumas, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 712 Riverview Dr, Brielle, NJ 08730 Phone: 732-528-2188    Fax: 732-528-4408

Brielle Integrated Healthcare Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 629 Higgins Ave, Brielle, NJ 08730 Phone: 732-872-6595

News Archive

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.

Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits

Researchers from Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and the National Heart, Lung and Blood Institute (NHLBI), have completed analyses of a genome-wide scan on a group of two generations of participants from the landmark Framingham Heart Study (FHS).

Could a mathematical application of information theory identify and predict SARS-CoV-2 mutations?

An interesting new study by researchers at the University of Portsmouth, UK, describes the use of a mathematical method to sequence genomes based on information theory. The method offers an alternative to clinical techniques, allowing mutations to be detected and possibly even predicted. In this way, it opens new research opportunities in bioinformatics and genetics.

Experts discuss therapeutic potential of medical cannabis in a symposium organized by MUHC

While debate about recreational marijuana use continues, researchers are investigating the effectiveness of cannabis for treating pain, spasticity, and a host of other medical problems. In a symposium organized by the McGill University Health Centre as part of the 2015 American Association for the Advancement of Science Annual Meeting held this week in San Jose, California, world-renowned experts from North America and the U.K. share their perspectives on the therapeutic potential of medical cannabis and explore the emerging science behind it.

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the first patient has been enrolled in the Company's pivotal Phase 3 clinical study, study 007, of FV-100 to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

Read more Medical News

› Verified 4 days ago